Concurrent Chemoradiation With or Without Durvalumab in Elderly Patients With Unresectable Stage III NSCLC: Safety and Efficacy-Reference-Cited by-同舟云学术

Concurrent Chemoradiation With or Without Durvalumab in Elderly Patients With Unresectable Stage III NSCLC: Safety and Efficacy

Published:2021-12 Issue:12 Volume:2 Page:100251
ISSN:2666-3643
Container-title:JTO Clinical and Research Reports
language:en
Short-container-title:JTO Clinical and Research Reports

Author:

Lau Sally C.M.,Ryan Malcolm,Weiss Jessica,Fares Aline Fusco,Garcia Miguel,Schmid Sabine,Kuang Shelley,Kelly Deirdre,Tsao Ming Sound,Bradbury Penelope A.,Cho Byoung Chun J.,Sun Alexander,Raman Srinivas,Hope Andrew,Giuliani Meredith,Lok Benjamin H.,Bezjak Andrea,Liu Geoffrey,Leighl Natasha B.,Shepherd Frances A.,Sacher Adrian G.

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference15 articles.

1. A review of the management of elderly patients with non-small-cell lung cancer;Blanco;Annals Oncol,2015

2. Lung cancer in the elderly;Gridelli;J Clin Oncol,2007

3. Overall survival with durvalumab after chemoradiotherapy in stage III NSCLC;Antonia;N Engl J Med,2018

4. Durvalumab after chemoradiotherapy in stage III non-small-cell lung cancer;Antonia;N Engl J Med,2017

5. Pooled analysis of individual patient data on concurrent chemoradiotherapy for stage III non-small-cell lung cancer in elderly patients compared with younger patients who participated in US National Cancer Institute Cooperative Group studies;Stinchcombe;J Clin Oncol,2017

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pneumonitis Risk After Chemoradiotherapy With and Without Immunotherapy in Patients With Locally Advanced Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis;International Journal of Radiation Oncology*Biology*Physics;2024-07

2. Durvalumab Consolidation After Chemoradiotherapy in Elderly Patients With Unresectable Stage III NSCLC: A Real-World Multicenter Study;Clinical Lung Cancer;2024-06

3. Herausforderungen in der multimodalen Therapie älterer Patient:innen mit Lungenkarzinomen;Die Onkologie;2024-01-02

4. Durvalumab Plus Concurrent Radiotherapy for Treatment of Locally Advanced Non–Small Cell Lung Cancer;JAMA Oncology;2023-11-01

5. Comparison of post-chemoradiotherapy pneumonitis between Asian and non-Asian patients with locally advanced non-small cell lung cancer: a systematic review and meta-analysis;eClinicalMedicine;2023-10